Now showing items 1-1 of 1
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
(Cancer Research UK and Nature Publishing Group, 2012)
BACKGROUND: Three quarter of endometrial carcinomas are treated at early stage. Still, 15 to 20% of these patients experience recurrence, with little effect from systemic therapies. Homo sapiens v-Ki-ras2 Kirsten rat ...